Clonal Selection of Hematopoietic Stem Cells after Gene Therapy for Sickle Cell Disease

Researchers used whole-genome sequencing to track HSCs from six patients with sickle cell disease at pre- and post-Gene therapy time points to map the somatic mutation and clonal landscape of gene-modified and unmodified HSCs.